SCHEMBL7801020

SCHEMBL7801020

CN(Cc1ccccc1)C(=O)c1cnc2c([N+](=O)[O-])cc(F)cc2c1Cl

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.43
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
THRA P10827 2/20 0.41
THRB P10828 2/20 0.41
PPARG P37231 1/20 0.41
KMT2A Q03164 4/20 0.40
APOBEC3A P31941 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 2/20 0.39
TACR1 P25103 1/20 0.39
CTSB P07858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7803244 0.86 ALDH1A1 (0.48) HSP90AA1ALDH1A1LMNAKMT2AAPOBEC3A
SCHEMBL7799276 0.83 ALDH1A1 (0.41) ALDH1A1LMNATHRATHRBPPARG
SCHEMBL926361 0.74 KMT2A (0.50) HSP90AA1ALDH1A1LMNAKMT2AATM
SCHEMBL6985100 0.67 MEN1 (0.35) ALDH1A1LMNAKMT2ASMN1; SMN2HPGD
SCHEMBL8303927 0.67 MEN1 (0.62) ALDH1A1LMNATHRBKMT2AHDAC6
SCHEMBL7793486 0.65 KMT2A (0.50) ALDH1A1KMT2AHDAC3HDAC4HDAC6
SCHEMBL7799113 0.65 SIRT2 (0.44) HSP90AA1ALDH1A1KMT2AAPOBEC3AHDAC3
SCHEMBL3818567 0.64 APOBEC3A (0.50) HSP90AA1ALDH1A1LMNAKMT2AAPOBEC3A
SCHEMBL30989930 0.63 HSP90AA1 (0.52) HSP90AA1ALDH1A1KMT2AHDAC3HDAC4
SCHEMBL6538436 0.63 ALDH1A1 (0.61) HSP90AA1ALDH1A1LMNATHRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010001101-A1 Phenanthroline derivatives ZENECA LIMITED 2001-05-10 US disclosed
EP-1027351-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 2000-08-16 EP disclosed
WO-1999021860-A1 PHENANTHROLINE DERIVATIVES FIBROGEN, INC. (US) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010001101-A1 Phenanthroline derivatives H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, COL1A1, COL2A1 HSP90AA1 1003/4885ALDH1A1 425/4885LMNA 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.